BioIVT

#DYK the number of people living with #Alzheimers dementia in America is projected to double to 13.8 million by 2060? Advancing our understanding of Alzheimer’s disease is essential to preparing for this oncoming public health challenge. At BioIVT, we are committed to supporting #neuroscience research through our comprehensive, ready-to-ship portfolio of longitudinally collected human cerebrospinal fluid (CSF) from both normal and diseased donor populations. Explore our banks and learn how BioIVT can support your Alzheimer's research efforts: https://hubs.ly/Q02ZKxtt0 #AlzheimersAwareness #AlzheimersResearch #BioIVTNeuroExcellence #NeuroscienceResearch

Did you know today is not only Thanksgiving but also Family Health History Day? Holiday gatherings offer a unique opportunity to discuss health issues that impact families across generations, and understanding your family health history is a vital step toward early diagnosis and prevention. Each year brings new scientific advancements that improve disease detection and treatment. Biomarkers are one such technology, providing an avenue for the development of new therapies as well as companion diagnostics. At BioIVT, we’re proud to support researchers advancing diagnostic methods through biomarker research. Their breakthroughs are enabling earlier disease detection and leading to more personalized therapeutics. Our global supply of ethically sourced, patient-derived samples and comprehensive clinical data provides researchers with the vitals tools they need to make significant breakthroughs in biomarker discovery and companion diagnostics. Learn more about our commitment to biomarker discovery and diagnostic research: https://hubs.ly/Q02ZKwrX0 #FamilyHealthHistoryDay #Biomarkers #PersonalizedMedicine #Diagnostics

To our incredible BioIVT team and customers: Great Science Starts with Great People—and that’s you! We’d be remiss this holiday season if we didn’t express our gratitude to each of you. Your dedication enables smarter science and the breakthroughs that enhance lives. We’re grateful for your hard work, creativity, and commitment to making a difference. Wishing you a happy and restful holiday! 🍁 #Thankful #Gratitude

At BioIVT, our commitment to science goes hand in hand with our dedication to making a difference in the communities we serve. Recently, our teams have taken time to give back in ways that support local causes aligned with our mission. Here are just a few highlights:    🏃♂️ 5K Run with the Cell & Gene Therapy Team: Members of our Cell & Gene Therapy team participated in a 5K, raising funds and awareness for cell and gene therapy research—a cause close to our hearts.  🎒 Backpack Filling in Detroit: Partnering with the United Way of Southeastern Michigan, our team packed 100 colorful bags with learning supplies, supporting at-home education for kids in need.  📚 Back-to-School Drive in Kansas City: Our Kansas team filled backpacks with essential supplies for children in foster care to start the school year with confidence.  🧑🎓 Harborfields High School Career Fair: Our VP of Scientific Affairs and Director of Human Resources spoke with students about career development and opportunities.   These initiatives embody our core values of Accountability, Integrity, and Customer Focus. Thank you to everyone who contributed—together, we’re advancing science and enriching lives, both in our industry and our communities.     #BioIVTvalues #GivingBack #CommunityImpact #AdvancingScience

With renewed interest in utilizing #psychedelics such as psilocybin, LSD, or MDMA as potential treatments for mental health disorders, Tina Mueller, PhD will share her expertise for an insightful webinar on important #drugdevelopment considerations, including: • #Pharmacology, mode of action, and #ADME properties • The current and next generation of psychedelics • Clinical trials • Challenges for psychedelic drug development Learn more and register here: https://hubs.ly/Q02ZksW60 #BioIVTNeuroExcellence #NeuroscienceResearch

A lack of basic data accompanying #biospecimens prevents researchers from ensuring relevancy and quality during procurement as well as eventual reproducibility, calling the results of critical research into question. Read about the importance of and ways to utilize basic data to help ensure the accuracy of your research, including several case studies highlighting its impact: https://lnkd.in/eNFH9hMM #Pharma #Biotech #DrugDiscovery #Research

Choosing the right cellular starting and raw materials vendor for your #CellandGeneTherapy program is crucial. Discover three key strategies to evaluate and find the perfect fit.  Download our full guide to learn more and make an informed decision for your #ATMPs ➡️ https://lnkd.in/g9nBWSuv #CellTherapy #GeneTherapy #AdvancedTherapies #QualityControl #VendorSelection

In recognition of #PancreaticCancerMonth, we’re spotlighting research advancing pancreatic cancer diagnostics. 🧬 The average lifetime risk of pancreatic cancer is about 1 in 56 for men and 1 in 60 for women, making early detection crucial. Recent studies have identified unique RNA "signatures" in the blood of cancer patients, especially RNAs from repetitive DNA sections. Using advanced technology, researchers analyzed cell-free RNA from blood plasma samples, including samples from patients with pancreatic cancer provided by BioIVT. During their study, they discovered that specific RNA patterns—like the Alu subfamilies—are particularly common in pancreatic cancer patients, providing a promising pathway for early diagnosis. By identifying these unique #biomarkers, researchers propel us closer to more precise, disease-specific diagnostic tools for #PancreaticCancer. Read the full study: https://hubs.ly/Q02YwmGV0 #PancreaticCancerAwareness #CancerResearch #EarlyDetection #Diagnostics

Understanding potential obstacles in the selection, utilization, and processing of #FFPEtissue is imperative for successful next-generation #sequencing (NGS). Formalin-fixed, paraffin-embedded (FFPE) #biospecimens provide a cost-effective, versatile resource for NGS applications. NGS can analyze genomes, epigenomes, and transcriptomes and has been considered a valuable method for analyzing molecules derived from FFPE tissue blocks. However, awareness and effective management of the limitations associated with FFPE samples, coupled with optimized library preparation, are fundamental for the successful clinical implementation of FFPE-derived NGS. Read more: https://lnkd.in/gpUZaFmT #Mutations #Diagnostics #Biomarkers #Bioinformatics #PrecisionMedicine

Dissociated #tumor cells (DTCs) contain lymphoid cell subsets, such as #Tcells, B cells and NK cells, which can be easily isolated using standard immunomagnetic selection. As such, they are an invaluable source of tumor-infiltrating #lymphocytes (TILs), which are of critical interest for cellular therapies targeting solid tumors. View the results of an analysis on BioIVT’s DTCs to assess the TIL populations therein including a breakdown of CD45+ populations across a variety of tumor types: https://lnkd.in/eFzWHgR4 BioIVT provides a wide range of tissue and isolated cellular preparations from a diverse donor population. View available #biospecimens here: https://lnkd.in/e7BrxFuB #ImmuneCells #CellTherapy #Oncology #CancerResearch #DrugDevelopment